RhoA WT allele loss unleashes the cancer driver function of RhoA E40Q
Journal of Clinical Investigation · 2026
DOI: 10.1172/jci201975 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2026. Verfasst von Justine Noujarède und 14 weiteren Autor:innen. Hauptthemen laut MEDLINE: rhoA GTP-Binding Protein, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Loss of Function Mutation. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HORIZON EUROPE Marie Sklodowska-Curie Actions, Novo Nordisk Fonden.
Abstract (Originalsprache)
Cancer hot spot mutations of unknown function often obscure the functional understanding of the molecular pathways underlying cancer formation and limit the progress of precision medicine. We investigated unresolved driver functions of RHOA in head and neck squamous cell carcinoma. Our investigation reveals that RHOA E40Q is a partial loss-of-function allele that paradoxically promotes tumorigenesis only in the absence of WT RhoA. Therefore, mice expressing RHOA E40Q specifically in keratinocytes lacking WT Rhoa spontaneously developed squamous cell carcinoma and had defective hair shaft formation. Mechanistically, this is related to increased replication stress and genome instability caused by aberrant expression of cell cycle regulators and DNA repair genes, independent of the classical RhoA effectors ROCK and DIAPH. These data establish RHOA E40Q as an unusual, context-dependent oncogenic driver: a seemingly inactive variant that unleashes its tumor-promoting potential only when the WT allele is absent.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Förderung
- HORIZON EUROPE Marie Sklodowska-Curie Actions
- Novo Nordisk Fonden
Zitieren
APA
Noujarède, J., Wang, Q., Kokkinogenis, E. P., Luo, Y., Cudina, I., Willaume, S., Mooser, C., Nguyen, L. P., Poulsen, M. F., Heijmerikx, S., Le Phan, T. H., He, X., Andersen, J. B., Sørensen, C. S., & Brakebusch, C. (2026). RhoA WT allele loss unleashes the cancer driver function of RhoA E40Q. Journal of Clinical Investigation. https://doi.org/10.1172/jci201975
Vancouver
Noujarède J, Wang Q, Kokkinogenis EP, Luo Y, Cudina I, Willaume S, et al. RhoA WT allele loss unleashes the cancer driver function of RhoA E40Q. Journal of Clinical Investigation. 2026. doi:10.1172/jci201975
BibTeX
@article{Noujarde2026,
author = {Noujarède, Justine and Wang, Qiuyue and Kokkinogenis, Eleftherios Panagiotis and Luo, Yuewan and Cudina, Ivona and Willaume, Simon and Mooser, Clémence and Nguyen, Lap Phuoc and Poulsen, Mads Frederik and Heijmerikx, Simon and Le Phan, Thu Han and He, Xiubin and Andersen, Jesper Bøje and Sørensen, Claus Storgaard and Brakebusch, Cord},
title = {RhoA WT allele loss unleashes the cancer driver function of RhoA E40Q},
journal = {Journal of Clinical Investigation},
year = {2026},
doi = {10.1172/jci201975}
}
EUVIMED